Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,249 | 96,312 | 8,438 | 14,250 | 66,981 |
| Marketable Securities | 5,207 | 35,701 | 83,144 | 112,119 | 82,769 |
| Receivables | 1,399 | 1,972 | 3,236 | 2,264 | 2,753 |
| Inventories | 1,207 | 1,227 | 1,008 | 798 | 808 |
| Other current assets | 3,500 | 3,500 | 3,500 | 3,500 | 3,500 |
| TOTAL | $102,382 | $146,492 | $105,419 | $138,794 | $162,797 |
| Non-Current Assets | |||||
| PPE Net | 23,205 | 24,057 | 11,341 | 11,614 | 11,707 |
| Intangibles | 21,992 | 22,626 | 18,399 | 13,733 | 14,066 |
| Other Non-Current Assets | 14,366 | 12,178 | 10,931 | 9,709 | 8,263 |
| TOTAL | $59,563 | $58,861 | $40,671 | $35,056 | $34,036 |
| Total Assets | $161,945 | $205,353 | $146,090 | $173,850 | $196,833 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,662 | 1,798 | 1,766 | 1,830 | 2,297 |
| Accounts payable and accrued liabilities | 6,131 | 4,618 | 4,031 | 1,063 | 923 |
| Accrued Expenses | 22,454 | 29,825 | 26,959 | 22,275 | 14,325 |
| TOTAL | $30,864 | $37,254 | $33,521 | $26,056 | $18,548 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,026 | 5,808 | 3,702 | 3,102 | 3,879 |
| Deferred Revenues | 617 | 1,013 | 765 | 888 | 1,003 |
| Other Non-Current Liabilities | 190,099 | 190,099 | 190,099 | 190,099 | 190,099 |
| TOTAL | $196,395 | $197,268 | $195,111 | $194,646 | $195,563 |
| Total Liabilities | $227,259 | $234,522 | $228,632 | $220,702 | $214,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 4 | 4 | 3 | 3 |
| Common Shares | 587,543 | 586,371 | 394,750 | 390,179 | 385,774 |
| Retained earnings | -644,338 | -606,881 | -470,486 | -433,819 | -401,700 |
| Other shareholders' equity | -8,519 | -8,659 | -6,806 | -3,212 | -1,352 |
| TOTAL | $-65,314 | $-29,169 | $-82,542 | $-46,852 | $-17,278 |
| Total Liabilities And Equity | $161,945 | $205,353 | $146,090 | $173,850 | $196,833 |